TOSYY yields 13.40% · PFE yields 6.13%● Live data
📍 TOSYY pulled ahead of the other in Year 1
Combined, TOSYY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TOSYY + PFE for your $10,000?
Toshiba Corporation, together with its subsidiaries, provides electronic devices and storage solutions worldwide. It operates through Energy Systems and Solutions, Infrastructure Systems and Solutions, Building Solutions, Retail and Printing Solutions, Electronic Devices and Storage Solutions, Digital Solutions, and Other segments. The company provides energy systems and solutions, including nuclear, thermal, and renewable energy power generation systems; transmission and distribution, hydro, geothermal, solar, and wind power services. It also offers infrastructure systems and solutions, such as water supply, sewerage, waste, subways, railways, airports, road, and ports service; security and automation, and motor/drive systems, equipment, facilities, maintenance services; telecommunication, power distribution, communication, and broadcast systems. In addition, the company provides building solutions comprising light fixtures, industrial light parts, commercial air-conditioner compressors, elevators, escalators for buildings and facilities, ventilation, and lighting, as well as energy-saving, environmentally products and services, and building solutions for security. Further, the company offers power, small-signal, and optoelectronic devices, In-vehicle digital and logic microcomputers, analog ICs, semiconductor manufacturing equipment , and parts materials. Additionally, it provides automotive, industrial semiconductors, manufacturing equipment, battery systems, and IT solution services. Toshiba Corporation was founded in 1875 and is headquartered in Tokyo, Japan.
Full TOSYY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.